Abstract A method of converting natural porcine insulin to human insulin by reversibly blocking the six carboxyl groups in porcine insulin, digesting the blocked porcine insulin with trypsin to remove the carboxyl terminal octapeptide from the porcine insulin B chain and generating a free carboxyl group in the arginine residue in position 22 of the B chain, and then reversibly blocking all amino groups preferably with BOC azide and coupling the free carboxyl at position 22 to a synthetic octapeptide which corresponds to the sequence at the carboxyl end of the B chain in human insulin, and finally removing all protecting groups from carboxyl and amino and purifying and recovering synthetic human insulin. This method is also susceptible to preparing radioactively labelled human insulin by utilizing radioactive amino acids in the synthesis of the octapeptide grafted or placed on the porcine residue. Further the present method also permits the facile synthesis of insulin analogs, since any selected amino acid sequence may be attached to the carboxyl group at position 22. The above method, in summary, by means of chemical and enzymatic treatment, makes possible the removal quantitatively and selectively of the carboxyl terminal octapeptide from the porcine insulin B chain. This fragment may be replaced by an analogous synthetic human octapeptide to give a protein which is identical to human insulin by a satisfying number of criteria.
A METHOD OF CONVERTING NATURAL PORCINE INSULIN TO HUMAN INSULIN BY A. REVERSIBLY BLOCKING THE SIX CARBOXYL GROUPS IN PORCINE INSULIN BY CONVERSION TO THE METHYL ESTERS, B. DIGESTING THE BLOCKED PORCINE INSULIN WITH TRYPSIN TO REMOVE THE CARBOXYL TERMINAL OCTAPEPTIDE FROM THE PORCINE INSULIN B CHAIN AND GENERATING A FREE CARBOXYL GROUP IN THE ARGININE RESIDUE IN POSITION 22 OF THE B CHAIN, C. REVERSIBLY BLOCKING ALL AMINO GROUPS WITH BOC AZIDE, D. COUPLING THE FREE CARBOXYL AT POSITION 22 TO A SYNTHETIC OCTAPEPTIDE WHICH CORRESPONDS TO THE SEQUENCE AT THE CARBOXYL END OF THE B CHAIN IN HUMAN INSULIN, E. REMOVING ALL PROTECTING GROUPS FROM CARBOXYL AND AMINO AND PURIFYING AND RECOVERING SYNTHETIC HUMAN INSULIN.
Claim 2
Independent Claim
117 words
A METHOD OF CONVERTING NATURAL PORCINE INSULIN TO HUMAN INSULIN BY A. REVERSIBLY BLOCKING THE SIX CARBOXYL GROUPS IN PORCINE INSULIN BY CONVERSION TO THE METHYL ESTERS, B. DIGESTING THE BLOCKED PORCINE INSULIN WITH TRYPSIN TO REMOVE THE CARBOXYL TERMINAL OCTAPEPTIDE FROM THE PORCINE INSULIN B CHAIN AND GENERATING A FREE CARBOXYL GROUP IN THE ARGININE RESIDUE IN POSITION 22 OF THE B CHAIN, C. REVERSIBLY BLOCKING ALL AMINO GROUPS WITH BOC AZIDE, D. COUPLING THE FREE CARBOXYL AT POSITION 22 TO A SYNTHETIC OCTAPEPTIDE WHICH CORRESPONDS TO THE SEQUENCE AT THE CARBOXYL END OF THE B CHAIN IN HUMAN INSULIN, E. REMOVING ALL PROTECTING GROUPS FROM CARBOXYL AND AMINO AND PURIFYING AND RECOVERING SYNTHETIC HUMAN INSULIN.
Claim 3
Dependent Claim
16 words
The method according to claim 1 wherein the amino groups are blocked with a BOC azide.
Claim 4
Dependent Claim
25 words
The method according to claim 1 wherein the six carboxyl groups of porcine insulin are reversibly blocked by the formation of methyl esters from diazomethane.
Claim 5
Dependent Claim
17 words
The method according to claim 1 wherein the synthetic octapeptide utilized for coupling agent is radioactively labelled.
Claim 6
Dependent Claim
15 words
The method according to claim 4 wherein the synthetic octapeptide utilized is radioactively internally labelled.